Grants & Funding


CARRA funds up to 2 travel awards for Early Investigators and/or fellows to attend the Pediatric Rheumatology European Society (PReS) annual meeting, and the preconference meeting for young/early investigators. This opportunity is open to all CARRA US and Canadian Early Investigators (<7 years post-fellowship) and fellow members. This is an outstanding meeting and a great chance to present your work and network.

Not currently accepting applications.

The goals of this travel award are to:

  1. Create collaboration between the CARRA Early Investigator group and the PReS Young Investigator group
  2. Give CARRA members an opportunity to give a scientific presentation (oral or poster) at an international meeting
  3. Allow CARRA members to attend the very highly-regarded Young Investigators Meeting
  4. Provide an opportunity for CARRA Early Investigators to network and collaborate with international colleagues


  1. Amount: Up to $2,500 per awardee to pay for registration and travel
  2. Awardees must register for and attend the Young Investigators Meeting :
  3. Meeting details:
  4. PReS abstract submission
  5. Awardees must commit to attending the entire meeting
  6. Abstracts accepted for this meeting will be published in Pediatric Rheumatology

To be considered for this travel award, applicants must submit the following:

  • Draft abstract

  • Personal statement: This should consist of less than one page describing yourself, your career goals, and any ongoing research projects. Include details on how you will benefit from this opportunity, and what, if any, specific impact your participation will have on CARRA.

  • CV or NIH Biosketch

  • Letter from your division chief stating that you will be allowed to take the time to attend the meeting

CARRA will review abstracts and make selections before the official abstract submission site closes.

Contact CARRA Grants Manager, Cassidy Mazurek ([email protected]) with questions about the application process.


These travel awards are made possible through the generous support of the Arthritis Foundation.